Great Basin Corporation Opens New, Expanded Manufacturing Facility to Meet Market Demand for Low-Cost, Easy-to-Use Molecular Diagnostics Tests
Published: Nov 13, 2012
SALT LAKE CITY--(BUSINESS WIRE)--Great Basin Corporation, a privately-held molecular diagnostics company developing sample-to-result solutions, today announced the opening of a new manufacturing facility. Dedicated to the manufacture of the company’s closed-system molecular diagnostics cartridges, the facility more than triples the company’s manufacturing capacity and is located adjacent to Great Basin’s administrative and R&D facility in Salt Lake City. Currently, the company is in full production manufacturing Clostridium difficile (C. diff) molecular diagnostic assay cards used in the company’s Portrait Analyzer. The new facility offers expansion capabilities to support future manufacturing needs for the company’s aggressive product roadmap of molecular assays to aid in the diagnosis of other critical hospital- acquired infections.